|
US796777A
(en)
|
1905-01-31 |
1905-08-08 |
Luigi Viezzi |
Support for floor construction.
|
|
US2386796A
(en)
|
1942-08-05 |
1945-10-16 |
Bond Crown & Cork Co |
Extruding device
|
|
DE2855719A1
(de)
|
1978-12-22 |
1980-07-10 |
Siemens Ag |
Zahnaerztliche handstueckanordnung
|
|
US4336336A
(en)
|
1979-01-12 |
1982-06-22 |
President And Fellows Of Harvard College |
Fused gene and method of making and using same
|
|
AU545912B2
(en)
|
1980-03-10 |
1985-08-08 |
Cetus Corporation |
Cloned heterologous jive products in bacillies
|
|
ZA811368B
(en)
|
1980-03-24 |
1982-04-28 |
Genentech Inc |
Bacterial polypedtide expression employing tryptophan promoter-operator
|
|
NZ199722A
(en)
|
1981-02-25 |
1985-12-13 |
Genentech Inc |
Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain
|
|
GR75411B
(enExample)
|
1981-04-29 |
1984-07-16 |
Biogen Nv |
|
|
US4551433A
(en)
|
1981-05-18 |
1985-11-05 |
Genentech, Inc. |
Microbial hybrid promoters
|
|
US4405712A
(en)
|
1981-07-01 |
1983-09-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
LTR-Vectors
|
|
US4603112A
(en)
|
1981-12-24 |
1986-07-29 |
Health Research, Incorporated |
Modified vaccinia virus
|
|
US4769330A
(en)
|
1981-12-24 |
1988-09-06 |
Health Research, Incorporated |
Modified vaccinia virus and methods for making and using the same
|
|
US4876197A
(en)
|
1983-02-22 |
1989-10-24 |
Chiron Corporation |
Eukaryotic regulatable transcription
|
|
CA1341116C
(en)
|
1983-02-22 |
2000-10-17 |
Rae Lyn Burke |
Yeast expression systems with vectors having gapdh or pyk promoters and synthesis or foreign protein
|
|
JPS59166086A
(ja)
|
1983-03-09 |
1984-09-19 |
Teruhiko Beppu |
新規な発現型プラスミドとそれらを用いて仔牛プロキモシン遺伝子を大腸菌内で発現させる方法
|
|
US4546083A
(en)
|
1983-04-22 |
1985-10-08 |
Stolle Research & Development Corporation |
Method and device for cell culture growth
|
|
US4588684A
(en)
|
1983-04-26 |
1986-05-13 |
Chiron Corporation |
a-Factor and its processing signals
|
|
JPS59205983A
(ja)
|
1983-04-28 |
1984-11-21 |
ジエネツクス・コ−ポレイシヨン |
異種遺伝子を原核微生物で発現させる方法
|
|
US4663280A
(en)
|
1983-05-19 |
1987-05-05 |
Public Health Research Institute Of The City Of New York |
Expression and secretion vectors and method of constructing vectors
|
|
EP0127839B1
(en)
|
1983-05-27 |
1992-07-15 |
THE TEXAS A&M UNIVERSITY SYSTEM |
Method for producing a recombinant baculovirus expression vector
|
|
US4689406A
(en)
|
1983-08-10 |
1987-08-25 |
Amgen |
Enhancement of microbial expression of polypeptides
|
|
US4870008A
(en)
|
1983-08-12 |
1989-09-26 |
Chiron Corporation |
Secretory expression in eukaryotes
|
|
JPS6054685A
(ja)
|
1983-09-02 |
1985-03-29 |
Suntory Ltd |
改良発現ベクタ−およびその利用
|
|
EP0136907A3
(en)
|
1983-10-03 |
1986-12-30 |
Genentech, Inc. |
A xenogeneic expression control system, a method of using it, expression vectors containing it, cells transformed thereby and heterologous proteins produced therefrom
|
|
ZA848495B
(en)
|
1984-01-31 |
1985-09-25 |
Idaho Res Found |
Production of polypeptides in insect cells
|
|
DE3587759T2
(de)
|
1984-05-11 |
1994-07-07 |
Chiron Corp., Emeryville, Calif. |
Erhöhte Hefetranskription unter Verwendung einer Hybridkonstruktion der Promotorregion.
|
|
US4880734A
(en)
|
1984-05-11 |
1989-11-14 |
Chiron Corporation |
Eukaryotic regulatable transcription
|
|
CA1282721C
(en)
|
1984-06-04 |
1991-04-09 |
Bernard Roizman |
Herpes simplex virus as a vector
|
|
US5288641A
(en)
|
1984-06-04 |
1994-02-22 |
Arch Development Corporation |
Herpes Simplex virus as a vector
|
|
US4738921A
(en)
|
1984-09-27 |
1988-04-19 |
Eli Lilly And Company |
Derivative of the tryptophan operon for expression of fused gene products
|
|
US4745056A
(en)
|
1984-10-23 |
1988-05-17 |
Biotechnica International, Inc. |
Streptomyces secretion vector
|
|
US4837148A
(en)
|
1984-10-30 |
1989-06-06 |
Phillips Petroleum Company |
Autonomous replication sequences for yeast strains of the genus pichia
|
|
US4762915A
(en)
|
1985-01-18 |
1988-08-09 |
Liposome Technology, Inc. |
Protein-liposome conjugates
|
|
US4797368A
(en)
|
1985-03-15 |
1989-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adeno-associated virus as eukaryotic expression vector
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
CA1260858A
(en)
|
1985-03-28 |
1989-09-26 |
Lawrence S. Cousens |
Expression using fused genes providing for protein product
|
|
US4865974A
(en)
|
1985-09-20 |
1989-09-12 |
Cetus Corporation |
Bacterial methionine N-terminal peptidase
|
|
US4777127A
(en)
|
1985-09-30 |
1988-10-11 |
Labsystems Oy |
Human retrovirus-related products and methods of diagnosing and treating conditions associated with said retrovirus
|
|
JPS6296086A
(ja)
|
1985-10-21 |
1987-05-02 |
Agency Of Ind Science & Technol |
複合プラスミド
|
|
US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
|
US5091309A
(en)
|
1986-01-16 |
1992-02-25 |
Washington University |
Sindbis virus vectors
|
|
US4861719A
(en)
|
1986-04-25 |
1989-08-29 |
Fred Hutchinson Cancer Research Center |
DNA constructs for retrovirus packaging cell lines
|
|
FI871919A7
(fi)
|
1986-05-02 |
1987-11-03 |
Gist Brocades Nv |
Erityssignaaliselektiovektoreita solunulkoiseen proteiinisynteesiin Bacillus-bakteereilla
|
|
ATE247708T1
(de)
|
1986-10-02 |
2003-09-15 |
Massachusetts Inst Technology |
Verfahren zur regulierung der metabolischen stabilität von proteinen
|
|
JPS63123383A
(ja)
|
1986-11-11 |
1988-05-27 |
Mitsubishi Kasei Corp |
ハイブリツドプロモ−タ−、発現調節ｄｎａ配列および発現ベクタ−
|
|
GB8702816D0
(en)
|
1987-02-07 |
1987-03-11 |
Al Sumidaie A M K |
Obtaining retrovirus-containing fraction
|
|
US5219740A
(en)
|
1987-02-13 |
1993-06-15 |
Fred Hutchinson Cancer Research Center |
Retroviral gene transfer into diploid fibroblasts for gene therapy
|
|
DE3888561T2
(de)
|
1987-03-23 |
1994-09-01 |
Zymogenetics Inc |
Hohe Proteinsyntheserate in Hefe.
|
|
US4980289A
(en)
|
1987-04-27 |
1990-12-25 |
Wisconsin Alumni Research Foundation |
Promoter deficient retroviral vector
|
|
WO1989001973A2
(en)
|
1987-09-02 |
1989-03-09 |
Applied Biotechnology, Inc. |
Recombinant pox virus for immunization against tumor-associated antigens
|
|
DK463887D0
(da)
|
1987-09-07 |
1987-09-07 |
Novo Industri As |
Gaerleader
|
|
JP3015383B2
(ja)
|
1987-09-11 |
2000-03-06 |
ホワイトヘツド・インスチチユート・フオー・バイオメデイカル・リサーチ |
形質導入した線維芽およびそれらの使用
|
|
US4929555A
(en)
|
1987-10-19 |
1990-05-29 |
Phillips Petroleum Company |
Pichia transformation
|
|
EP0318216B2
(en)
|
1987-11-18 |
2001-08-29 |
Chiron Corporation |
NANBV diagnostics
|
|
WO1989005349A1
(en)
|
1987-12-09 |
1989-06-15 |
The Australian National University |
Method of combating viral infections
|
|
CA1340772C
(en)
|
1987-12-30 |
1999-09-28 |
Patricia Tekamp-Olson |
Expression and secretion of heterologous protiens in yeast employing truncated alpha-factor leader sequences
|
|
US4973551A
(en)
|
1988-01-15 |
1990-11-27 |
Merck & Co., Inc. |
Vector for the expression of fusion proteins and protein immunogens
|
|
WO1989009271A1
(en)
|
1988-03-21 |
1989-10-05 |
Viagene, Inc. |
Recombinant retroviruses
|
|
US5662896A
(en)
|
1988-03-21 |
1997-09-02 |
Chiron Viagene, Inc. |
Compositions and methods for cancer immunotherapy
|
|
US5591624A
(en)
|
1988-03-21 |
1997-01-07 |
Chiron Viagene, Inc. |
Retroviral packaging cell lines
|
|
US5206152A
(en)
|
1988-04-08 |
1993-04-27 |
Arch Development Corporation |
Cloning and expression of early growth regulatory protein genes
|
|
US5422120A
(en)
|
1988-05-30 |
1995-06-06 |
Depotech Corporation |
Heterovesicular liposomes
|
|
AP129A
(en)
|
1988-06-03 |
1991-04-17 |
Smithkline Biologicals S A |
Expression of retrovirus gag protein eukaryotic cells
|
|
JP3082204B2
(ja)
|
1988-09-01 |
2000-08-28 |
ホワイトヘッド・インスティチュート・フォー・バイオメディカル・リサーチ |
両栄養性および環境栄養性宿主域を持つ組換え体レトロウイルス
|
|
DE3841091A1
(de)
|
1988-12-07 |
1990-06-13 |
Behringwerke Ag |
Synthetische antigene, verfahren zu ihrer herstellung und ihre verwendung
|
|
US5217879A
(en)
|
1989-01-12 |
1993-06-08 |
Washington University |
Infectious Sindbis virus vectors
|
|
EP0378881B1
(en)
|
1989-01-17 |
1993-06-09 |
ENIRICERCHE S.p.A. |
Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines
|
|
WO1990007936A1
(en)
|
1989-01-23 |
1990-07-26 |
Chiron Corporation |
Recombinant therapies for infection and hyperproliferative disorders
|
|
CA2045129A1
(en)
|
1989-02-01 |
1990-08-02 |
Alfred I. Geller |
Herpes simplex virus type i expression vector
|
|
JP3140757B2
(ja)
|
1989-02-06 |
2001-03-05 |
デイナ・フアーバー・キヤンサー・インステイテユート |
パッケージング欠陥ｈｉｖプロウイルス、細胞系及びその使用
|
|
HU218717B
(hu)
|
1989-03-17 |
2000-11-28 |
E. I. Du Pont De Nemours And Co. |
Nukleinsav-termelést fokozó növényi eredetű génfragmentek és eljárás előállításukra
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
ATE240401T1
(de)
|
1989-03-21 |
2003-05-15 |
Vical Inc |
Expression von exogenen polynukleotidsequenzen in wirbeltieren
|
|
JPH0832638B2
(ja)
|
1989-05-25 |
1996-03-29 |
カイロン コーポレイション |
サブミクロン油滴乳剤を含んで成るアジュバント製剤
|
|
DE4091460C2
(de)
|
1989-08-15 |
1996-05-09 |
Pasminco Australia Ltd |
Absorption von Zinkdampf in geschmolzenem Blei
|
|
EP0487587A1
(en)
|
1989-08-18 |
1992-06-03 |
Chiron Corporation |
Recombinant retroviruses delivering vector constructs to target cells
|
|
US5585362A
(en)
|
1989-08-22 |
1996-12-17 |
The Regents Of The University Of Michigan |
Adenovirus vectors for gene therapy
|
|
US5166057A
(en)
|
1989-08-28 |
1992-11-24 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand rna virus expression-systems
|
|
GB8919607D0
(en)
|
1989-08-30 |
1989-10-11 |
Wellcome Found |
Novel entities for cancer therapy
|
|
IT1237764B
(it)
|
1989-11-10 |
1993-06-17 |
Eniricerche Spa |
Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
|
|
AU7007491A
(en)
|
1990-02-02 |
1991-08-08 |
Schweiz. Serum- & Impfinstitut Bern |
Cdna corresponding to the genome of negative-strand rna viruses, and process for the production of infectious negative-strand rna viruses
|
|
NZ237464A
(en)
|
1990-03-21 |
1995-02-24 |
Depotech Corp |
Liposomes with at least two separate chambers encapsulating two separate biologically active substances
|
|
CA2039921A1
(en)
|
1990-04-16 |
1991-10-17 |
Xandra O. Breakefield |
Transfer and expression of gene sequences into central nervous system cells using herpes simplex virus mutants with deletions in genes for viral replication
|
|
AU7906691A
(en)
|
1990-05-23 |
1991-12-10 |
United States of America, as represented by the Secretary, U.S. Department of Commerce, The |
Adeno-associated virus (aav)-based eucaryotic vectors
|
|
US5149655A
(en)
|
1990-06-21 |
1992-09-22 |
Agracetus, Inc. |
Apparatus for genetic transformation
|
|
DE69113564T2
(de)
|
1990-08-13 |
1996-05-30 |
American Cyanamid Co |
Faser-Hemagglutinin von Bordetella pertussis als Träger für konjugierten Impfstoff.
|
|
CA2092195C
(en)
|
1990-09-21 |
2000-04-18 |
Douglas J. Jolly |
Retroviral packaging cell line
|
|
US5173414A
(en)
|
1990-10-30 |
1992-12-22 |
Applied Immune Sciences, Inc. |
Production of recombinant adeno-associated virus vectors
|
|
WO1992007945A1
(en)
|
1990-10-30 |
1992-05-14 |
Dana Farber Cancer Institute |
Cell type specific alteration of levels of gene products in neural cells
|
|
SE9003978D0
(sv)
|
1990-12-13 |
1990-12-13 |
Henrik Garoff |
Dna expressionssystem baserade paa ett virus replikon
|
|
ES2144414T3
(es)
|
1990-12-20 |
2000-06-16 |
Arch Dev Corp The University O |
Control de la expresion de un gen por medio de una radiacion ionizante.
|
|
IT1244706B
(it)
|
1991-02-07 |
1994-08-08 |
Sclavo Spa |
Plasmide pctd isolato da chlamydia trachomatis serotipo d, suoi geni e proteine da essi codificate; plasmidi ricombinanti per l'espressionedi detti geni in sistemi eterologhi come proteine ricombinanti di fusione, preparazione di dette proteine ricombinanti e loro uso nella formulazione di vaccini e/o diagnostici
|
|
AU663725B2
(en)
|
1991-08-20 |
1995-10-19 |
United States Of America, Represented By The Secretary, Department Of Health And Human Services, The |
Adenovirus mediated transfer of genes to the gastrointestinal tract
|
|
FR2681786A1
(fr)
|
1991-09-27 |
1993-04-02 |
Centre Nat Rech Scient |
Vecteurs recombinants d'origine virale, leur procede d'obtention et leur utilisation pour l'expression de polypeptides dans des cellules musculaires.
|
|
IL103059A0
(en)
|
1991-09-30 |
1993-02-21 |
Boehringer Ingelheim Int |
Conjugates for introducing nucleic acid into higher eucaryotic cells
|
|
NZ244306A
(en)
|
1991-09-30 |
1995-07-26 |
Boehringer Ingelheim Int |
Composition for introducing nucleic acid complexes into eucaryotic cells, complex containing nucleic acid and endosomolytic agent, peptide with endosomolytic domain and nucleic acid binding domain and preparation
|
|
US5252479A
(en)
|
1991-11-08 |
1993-10-12 |
Research Corporation Technologies, Inc. |
Safe vector for gene therapy
|
|
WO1993010218A1
(en)
|
1991-11-14 |
1993-05-27 |
The United States Government As Represented By The Secretary Of The Department Of Health And Human Services |
Vectors including foreign genes and negative selective markers
|
|
GB9125623D0
(en)
|
1991-12-02 |
1992-01-29 |
Dynal As |
Cell modification
|
|
CA2128616A1
(en)
|
1992-01-23 |
1993-08-05 |
Gary H. Rhodes |
Ex vivo gene transfer
|
|
IT1262896B
(it)
|
1992-03-06 |
1996-07-22 |
|
Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
|
|
FR2688514A1
(fr)
|
1992-03-16 |
1993-09-17 |
Centre Nat Rech Scient |
Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant.
|
|
JPH07507689A
(ja)
|
1992-06-08 |
1995-08-31 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
特定組織のターゲティング方法及び組成物
|
|
JPH09507741A
(ja)
|
1992-06-10 |
1997-08-12 |
アメリカ合衆国 |
ヒト血清による不活性化に耐性のあるベクター粒子
|
|
GB2269175A
(en)
|
1992-07-31 |
1994-02-02 |
Imperial College |
Retroviral vectors
|
|
CA2145535C
(en)
|
1992-09-25 |
2007-07-17 |
Axel Kahn |
Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain
|
|
AU694097B2
(en)
|
1992-11-18 |
1998-07-16 |
Arch Development Corporation |
Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle
|
|
JPH08503855A
(ja)
|
1992-12-03 |
1996-04-30 |
ジェンザイム・コーポレイション |
嚢胞性線維症に対する遺伝子治療
|
|
US5478745A
(en)
|
1992-12-04 |
1995-12-26 |
University Of Pittsburgh |
Recombinant viral vector system
|
|
US5348358A
(en)
|
1993-02-22 |
1994-09-20 |
Selick David A |
Contact lens insertion tool
|
|
DE4311651A1
(de)
|
1993-04-08 |
1994-10-13 |
Boehringer Ingelheim Int |
Virus für den Transport von Fremd-DNA in höhere eukaryotische Zellen
|
|
ATE227979T1
(de)
|
1993-04-22 |
2002-12-15 |
Skyepharma Inc |
Multivesikuläre liposomen mit verkapseltem cyclodextrin und pharmakologisch wirksamen verbindungen sowie verfahren zu deren verwendung
|
|
WO1994028157A1
(en)
|
1993-05-26 |
1994-12-08 |
The United States Government As Represented By The Secretary Of The Department Of Health And Human Services |
Fusion proteins containing adeno-associated virus rep protein and bacterial protein
|
|
FR2705686B1
(fr)
|
1993-05-28 |
1995-08-18 |
Transgene Sa |
Nouveaux adénovirus défectifs et lignées de complémentation correspondantes.
|
|
ES2249761T3
(es)
|
1993-06-24 |
2006-04-01 |
Advec Inc. |
Vectores de adenovirus para terapia genica.
|
|
KR100356615B1
(ko)
|
1993-07-13 |
2003-04-03 |
아방티 파르마 소시에테 아노님 |
결함아데노바이러스벡터및유전자치료에서그의사용
|
|
CA2167706A1
(en)
|
1993-07-27 |
1995-02-09 |
Nigel Fraser |
Modified dna virus vectors and uses therefor
|
|
US5631236A
(en)
|
1993-08-26 |
1997-05-20 |
Baylor College Of Medicine |
Gene therapy for solid tumors, using a DNA sequence encoding HSV-Tk or VZV-Tk
|
|
US5362865A
(en)
|
1993-09-02 |
1994-11-08 |
Monsanto Company |
Enhanced expression in plants using non-translated leader sequences
|
|
EP0694070B1
(en)
|
1993-09-15 |
2002-04-10 |
Chiron Corporation |
Recombinant alphavirus vectors
|
|
FR2710536B1
(fr)
|
1993-09-29 |
1995-12-22 |
Transgene Sa |
Usage anti-cancéreux d'un vecteur viral comportant un gène modulateur de la réponse immunitaire et/ou inflammatoire.
|
|
JPH09505561A
(ja)
|
1993-10-01 |
1997-06-03 |
アメリカ合衆国 |
神経系の遺伝子治療
|
|
SK283703B6
(sk)
|
1993-10-25 |
2003-12-02 |
Canji, Inc. |
Rekombinantný adenovírusový vektor a jeho použitie
|
|
BR9407986A
(pt)
*
|
1993-11-03 |
1996-12-03 |
Pfizer |
Vacina e método para tratamento de infecçoes clamídicas
|
|
US5693506A
(en)
|
1993-11-16 |
1997-12-02 |
The Regents Of The University Of California |
Process for protein production in plants
|
|
DK0729351T3
(da)
|
1993-11-16 |
2000-10-16 |
Skyepharma Inc |
Vesikler med reguleret afgivelse af aktivstoffer
|
|
FR2712603B1
(fr)
|
1993-11-18 |
1996-02-09 |
Centre Nat Rech Scient |
Virus recombinants, préparation et utilisation en thérapie génique.
|
|
JPH07241786A
(ja)
|
1994-03-08 |
1995-09-19 |
Fanuc Ltd |
産業用ロボットの制御装置
|
|
US6780406B1
(en)
|
1994-03-21 |
2004-08-24 |
The Regents Of The University Of Michigan |
Inhibition of vascular smooth muscle cell proliferation administering a thymidine kinase gene
|
|
US7252989B1
(en)
|
1994-04-04 |
2007-08-07 |
Board Of Regents, The University Of Texas System |
Adenovirus supervector system
|
|
US5629167A
(en)
|
1994-04-19 |
1997-05-13 |
Biocine S.P.A. |
Detection of antibodies against Chlamydia trachomatis pgp3 antigen in patient sera by enzyme-linked immunosorbent assay
|
|
CA2189067A1
(en)
|
1994-04-28 |
1995-11-09 |
Gary J. Nabel |
Gene delivery vector using plasmid dna packaged into an adenovirus and a packaging cell line
|
|
JP4303315B2
(ja)
|
1994-05-09 |
2009-07-29 |
オックスフォード バイオメディカ（ユーケー）リミテッド |
非交差性レトロウイルスベクター
|
|
ATE336587T1
(de)
|
1994-06-10 |
2006-09-15 |
Genvec Inc |
Adenoviren-vektor systeme und zelllinien
|
|
FR2723588B1
(fr)
|
1994-08-12 |
1996-09-20 |
Rhone Poulenc Rorer Sa |
Adenovirus comprenant un gene codant pour la glutathion peroxydase
|
|
IL117483A
(en)
|
1995-03-17 |
2008-03-20 |
Bernard Brodeur |
MENINGITIDIS NEISSERIA shell protein is resistant to proteinase K.
|
|
JPH11505128A
(ja)
|
1995-05-22 |
1999-05-18 |
カイロン コーポレイション |
キメラインテグラーゼタンパク質に媒介される真核生物ゲノム中へのベクター構築物の位置特異的組み込み
|
|
US5753235A
(en)
|
1996-02-15 |
1998-05-19 |
Heska Corporation |
Recombinant canine herpesviruses
|
|
DE19630390A1
(de)
|
1996-07-26 |
1998-01-29 |
Chiron Behring Gmbh & Co |
Proteine, insbesondere Membranproteine von Helicobacter pylori, ihre Herstellung und Verwendung
|
|
US5980898A
(en)
|
1996-11-14 |
1999-11-09 |
The United States Of America As Represented By The U.S. Army Medical Research & Material Command |
Adjuvant for transcutaneous immunization
|
|
GB9713156D0
(en)
|
1997-06-20 |
1997-08-27 |
Microbiological Res Authority |
Vaccines
|
|
US7459524B1
(en)
*
|
1997-10-02 |
2008-12-02 |
Emergent Product Development Gaithersburg Inc. |
Chlamydia protein, sequence and uses thereof
|
|
EP1029052B1
(en)
|
1997-11-06 |
2010-08-04 |
Novartis Vaccines and Diagnostics S.r.l. |
Neisserial antigens
|
|
ES2278420T3
(es)
|
1997-11-21 |
2007-08-01 |
Serono Genetics Institute S.A. |
Secuencia genomica y polipeptidos de chlamydia pneumoniae, fragmentos de los mismos y uso de los mismos, en particular para diagnostico, prevencion y tratamiento de infeccion.
|
|
CN1280619A
(zh)
*
|
1997-11-28 |
2001-01-17 |
根瑟特公司 |
沙眼衣原体的基因组序列和多肽,其片段以及其用途,特别是用于诊断、预防和治疗感染
|
|
US7041490B1
(en)
*
|
1997-11-28 |
2006-05-09 |
Serono Genetics Institute, S.A. |
Chlamydia trachomatis polynucleotides and vectors, recombinant host cells, DNA chips or kits containing the same
|
|
AU1979599A
(en)
|
1998-01-14 |
1999-08-02 |
Chiron S.P.A. |
(neisseria meningitidis) antigens
|
|
CN100379757C
(zh)
|
1998-05-01 |
2008-04-09 |
希龙公司 |
脑膜炎奈瑟球菌抗原和组合物
|
|
JP2004511201A
(ja)
|
1998-10-09 |
2004-04-15 |
カイロン コーポレイション |
ナイセリアゲノム配列およびそれらの使用方法
|
|
AU1722300A
(en)
|
1998-11-12 |
2000-05-29 |
Regents Of The University Of California, The |
Chlamydia pneumoniae genome sequence
|
|
US6565856B1
(en)
|
1998-12-08 |
2003-05-20 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
|
US20020061848A1
(en)
*
|
2000-07-20 |
2002-05-23 |
Ajay Bhatia |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
|
TR200102500T2
(tr)
*
|
1998-12-08 |
2002-03-21 |
Corixa Corporation |
Chlamydia enfeksiyonunu tedavi etmek iin bileçikler.
|
|
GB9828000D0
(en)
|
1998-12-18 |
1999-02-10 |
Chiron Spa |
Antigens
|
|
KR100642044B1
(ko)
|
1999-03-19 |
2006-11-10 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
백신
|
|
EP1165796A2
(en)
|
1999-04-09 |
2002-01-02 |
Techlab, Inc. |
Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines
|
|
CA2871789C
(en)
|
2000-01-17 |
2017-04-04 |
Novartis Vaccines And Diagnostics S.R.L. |
Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins
|
|
AU2001255596A1
(en)
|
2000-04-21 |
2001-11-07 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
|
US6919187B2
(en)
|
2000-04-21 |
2005-07-19 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
|
ATE440861T1
(de)
|
2000-07-03 |
2009-09-15 |
Novartis Vaccines & Diagnostic |
Immunisierung gegen chlamydia pneumoniae
|
|
US7939087B2
(en)
|
2000-10-27 |
2011-05-10 |
Novartis Vaccines And Diagnostics, Inc. |
Nucleic acids and proteins from Streptococcus groups A & B
|
|
CA2434490C
(en)
*
|
2001-01-17 |
2014-06-03 |
Intreat Pty Limited |
Antibodies to non-functional p2x7 receptor diagnosis and treatment of cancers and other conditions
|
|
WO2010065473A2
(en)
|
2008-12-01 |
2010-06-10 |
Applied Materials, Inc. |
Gas distribution blocker apparatus
|
